Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: Results from the SIMONE study - 08/08/11
, Giustino Parruti b, Tiziana Quirino c, Elena Ricci d, Giuseppe Schillaci e, Beatrice Adriani f, Patrizia Marconi g, Marzia Franzetti h, Canio Martinelli i, Francesca Vichi j, Giovanni Penco k, Claudio Sfara a, Giordano Madeddu l, Paolo Bonfanti dfor the CISAI study group
Corresponding author. Clinica di Malattie Infettive, Ospedale “Santa Maria della Misericordia”, Piazzale Menghini 1, 06129 Perugia, Italy. Tel.: +39 075 578 4358; fax: +39 075 578 4346.Summary |
Objective |
To identify and characterize HIV-infected patients at higher cardiovascular risk in ordinary clinical settings.
Design |
Multicenter, nationwide cross-sectional study.
Methods |
Consecutive HIV-patients, attending scheduled visits at facilities involved in the Italian coordination group for the study of allergies and HIV infection (CISAI), were included between February and April, 2005. Their 10-year probability of acute coronary events was calculated using the Framingham Risk Score (FRS) as well as 3 other cardiovascular algorithms (“PROCAM”, “PROGETTO CUORE”, “SCORE”); Metabolic Syndrome (MS) was diagnosed according to the National Cholesterol Education Program definitions. An estimated 10-year CVD ≥10% and/or MS led to the diagnosis of high CV risk. We compared selected clinical features between high- and low-risk patients.
Results |
A total of 1230 HIV infected patients (72% males, mean age of 43±9years), 185 of whom treatment-naïve, were evaluated. FRS gave the highest estimate of CV risk. The mean 10-year risk for acute coronary events according to FRS was 7.4±7.0. MS was present in 22% of the observed patients. Accordingly, 443 patients (36%) were classified at high risk. Twelve percent of the patients (n=142) had both a FRS ≥10% and a diagnosis of MS. The main single predictor of increased cardiovascular risk was smoking (60% of whole sample). A higher prevalence of clinically evident lipodystrophy and a higher CD4 T-cell counts were found both in patients with higher FRS and in patients with high FRS and MS (both p<0.001).
Conclusions |
The worst estimation of CV risk was obtained with the FRS algorithm. Clinical evidence of lipodystrophy and higher CD4 T-cell counts were closely associated to a worse cardiovascular risk profile.
Le texte complet de cet article est disponible en PDF.Keywords : Antiretroviral therapy, HIV, Metabolic Syndrome, Framingham Risk Score, Cardiovascular disease, Lipodystrophy, Arteriosclerosis
Plan
Vol 57 - N° 1
P. 33-40 - juillet 2008 Retour au numéro
Article précédent
- Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy
- Leonardo Calza, Roberto Manfredi, Daria Pocaterra, Francesco Chiodo
- Total joint replacement in HIV positive patients
- Bjoern Habermann, Christian Eberhardt, Andreas A. Kurth
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?